Zhongming Ge Selected Research

Zhongming Ge Research Topics

Disease

23	Infections 03/2023 - 04/2002
18	Neoplasms (Cancer) 01/2023 - 06/2003
14	Inflammation (Inflammations) 01/2023 - 02/2005
11	Carcinogenesis 01/2023 - 09/2003
9	Stomach Neoplasms (Stomach Cancer) 01/2023 - 06/2005
8	Gastritis 01/2022 - 02/2004
5	Hyperplasia 01/2020 - 06/2005
4	Metaplasia 01/2023 - 08/2011
4	Carcinoma (Carcinomatosis) 08/2009 - 01/2006
3	Anemia 03/2023 - 01/2015
3	Adenocarcinoma 01/2023 - 06/2003
3	Hepatitis 01/2022 - 07/2008
3	Gallstones (Gallstone) 01/2013 - 01/2006
3	Colitis 12/2008 - 02/2004
2	Persistent Infection 03/2023 - 07/2008
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2012 - 09/2003
2	Atrophy 08/2011 - 06/2005
1	Stomach Diseases 02/2024
1	Iron Deficiencies 03/2023
1	Barrett Esophagus (Barrett's Esophagus) 01/2023
1	Pneumonia (Pneumonitis) 01/2022
1	Meningoencephalitis 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Pyelonephritis 01/2022
1	Dysbiosis 01/2020
1	Hemorrhage 01/2020
1	Vitamin K Deficiency 01/2020
1	Meningitis 01/2018
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2017
1	Intestinal Neoplasms (Intestinal Cancer) 04/2015
1	Coinfection 04/2014
1	Cholelithiasis 01/2013
1	Edema (Dropsy) 12/2012
1	Typhlitis 12/2012
1	Necrosis 06/2011

Drug/Important Bio-Agent (IBA)

10	CytokinesIBA 12/2019 - 09/2003
10	Messenger RNA (mRNA)IBA 12/2019 - 08/2007
7	Interleukin-10 (Interleukin 10)IBA 01/2019 - 09/2003
6	InterleukinsIBA 01/2023 - 09/2003
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2011 - 02/2005
3	IronIBA 03/2023 - 01/2015
3	GastrinsIBA 01/2023 - 06/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2008
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 04/2010
3	colibactinIBA 01/2019 - 12/2016
3	cytolethal distending toxinIBA 01/2019 - 06/2005
3	CholesterolIBA 01/2013 - 01/2006
3	Immunoglobulin G (IgG)IBA 09/2012 - 02/2004
3	Interleukin-6 (Interleukin 6)IBA 04/2010 - 08/2007
2	Virulence Factors (Pathogenicity Factors)IBA 03/2023 - 01/2022
2	Cytotoxins (Cytolysins)IBA 03/2023 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2018
2	Insulin (Novolin)FDA Link 01/2023 - 01/2011
2	CateninsIBA 01/2023 - 01/2022
2	MucinsIBA 12/2019 - 01/2013
2	Dietary IronIBA 01/2017 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 07/2012 - 01/2012
2	Interferon-gamma (Interferon, gamma)IBA 10/2011 - 06/2007
2	NF-kappa B (NF-kB)IBA 08/2008 - 02/2004
2	Dihydrotachysterol (AT 10)IBA 12/2007 - 08/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2006 - 05/2005
1	CarcinogensIBA 02/2024
1	Hemoglobins (Hemoglobin)IBA 03/2023
1	MicronutrientsIBA 03/2023
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2022
1	16S Ribosomal RNAIBA 01/2022
1	Drinking WaterIBA 01/2022
1	Histocompatibility Antigens Class IIIBA 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	spasmolytic polypeptideIBA 12/2019
1	ClusterinIBA 12/2019
1	Trefoil FactorsIBA 12/2019
1	Griffonia simplicifolia lectinsIBA 12/2019
1	Interleukin-22 (IL-22)IBA 01/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2017
1	Peroxidase (Myeloperoxidase)IBA 04/2015
1	Ferritins (Ferritin)IBA 01/2015
1	Interleukin-11 (Interleukin 11)IBA 01/2014
1	Liposomes (Liposome)IBA 12/2012
1	HypoxanthineIBA 07/2012
1	RNA (Ribonucleic Acid)IBA 07/2012
1	5-chlorocytosineIBA 07/2012
1	Tamoxifen FDA LinkGeneric 09/2011
1	Estrogens (Estrogen)FDA Link 09/2011
1	salicylhydroxamic acid (SHAM)IBA 08/2011
1	Gonadal Steroid Hormones (Sex Hormones)IBA 08/2011
1	LigandsIBA 06/2011
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 06/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2011
1	ChemokinesIBA 06/2011
1	XenobioticsIBA 04/2011
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2011
1	Chenodeoxycholic Acid (Chenix)FDA Link 04/2011
1	Bile Acids and Salts (Bile Acids)IBA 04/2011
1	Toll-Like Receptor 2IBA 04/2011

Therapy/Procedure

3	Therapeutics 04/2015 - 09/2003
2	Aftercare (After-Treatment) 09/2011 - 12/2007
1	Intraperitoneal Injections 01/2013
1	Castration 08/2011